Instruction for use: Bidop

Trade name of the drug – Bidop

Dosage Form: tablets

Active substance: Bisoprololum

ATX

C07AB07 bisoprolol

Pharmacotherapeutic group: Beta1-selective blocker [Beta-blockers]

The nosological classification (ICD-10)

I10 Essential (primary) hypertension: hypertension; Arterial hypertension; Arterial hypertension crisis course; Essential Hypertension; Essential hypertension; Essential hypertension; Essential hypertension; Essential hypertension; Primary hypertension; Arterial hypertension, complications of diabetes; The sudden increase in blood pressure; Hypertensive disorders of blood circulation; hypertensive condition; hypertensive crises; arterial Hypertension; malignant Hypertension; Hypertonic disease; hypertensive crises; accelerated hypertension; malignant hypertension; The aggravation of hypertensive disease; Transient hypertension; Isolated systolic hypertension

I15 Secondary hypertension: Arterial hypertension, complications of diabetes; hypertension; The sudden increase in blood pressure; Hypertensive disorders of blood circulation; hypertensive condition; hypertensive crises; hypertension; arterial Hypertension; malignant Hypertension; hypertensive crises; accelerated hypertension; malignant hypertension; The aggravation of hypertensive disease; Transient hypertension; hypertension; Arterial hypertension; Arterial hypertension crisis course; renovascular hypertension; Hypertension symptomatic; Renal hypertension; Renovascular hypertension; renovascular hypertension; Symptomatic hypertension

I20 Angina [angina]: Heberden disease; Angina pectoris; The attack of angina pectoris; recurrent angina; Spontaneous angina; Stable angina pectoris; Angina rest; Angina progressing; Angina mixed; Angina spontaneous; stable angina; Chronic stable angina; Angina Syndrome X

Composition (per tablet):

active substance: bisoprolol hemifumarate 5 mg; 10 mg

Excipients: lactose monohydrate; MCC; magnesium stearate; crospovidone; Pigment brand PB-22812 yellow (lactose monohydrate - 87%, iron oxide yellow - 13%) - for the dosage of 5 mg; PB-27215 brand beige pigment (lactose monohydrate - 87%, iron oxide red and yellow - 13%) - for the dosage of 10 mg

Pharmacological Properties of Bidop

Pharmachologic effect - antianginal, hypotensive, anti-arrhythmic.

Dosage and Administration

Inside, in the morning, on an empty stomach, not liquid, once. The dose should be adjusted individually.

Arterial hypertension and coronary heart disease: prevention of attacks of stable angina usually starting dose is 5 mg 1 time per day.

If necessary to increase the dose of 10 mg 1 time per day. The maximum daily dose - 20 mg. In patients with impaired renal function if Cl creatinine <20 ml / min, or with severe liver problems, the maximum daily dose - 10 mg. Increasing the dose in such patients should be carried out with extreme caution.

Dose adjustment in elderly patients is not required.

Release Form

Tablets 5 mg, 10 mg. The blister PVC / PVDC / aluminum 14 pc. 1, 2 or 4 blisters in a carton box.

Manufacturer

Nis generics Limited, Ireland. Unit 5, Baldoyle Industrial Property, 151, Dublin, Republic of Ireland.

Prepackaged: 1. Nis generics Limited, Ireland. Unit 5, Baldoyle Industrial Property, 151, Dublin, Republic of Ireland.

2. CJSC "Gedeon Richter-Rus". 140342, Russia, Moscow region., Pos. Shuvoye.

Tel. / Fax: (495) 788-86-30.

The owner of the registration certificate: JSC "Gedeon Richter", Budapest, Hungary.

Claims consumer guide at the Moscow Representation of "Gedeon Richter". 119049, Moscow, 4th Dobryninsky per., 8.

Conditions of supply of pharmacies

On prescription.

Storage conditions of Bidop

In a dry, dark place at a temperature no higher than 25 ° C.

Keep out of the reach of children.

Shelf life

3 years.

Do not use beyond the expiration date printed on the package.